CG Oncology, Inc Common stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,157 | $1,083 | $2,322 | $1,666 |
Gross Profit | -2,768 | -1,879 | -592 | 89 |
EBITDA | -79,056 | -59,361 | -40,460 | -43,392 |
EBIT | -60,202 | -41,309 | -43,808 | |
Net Income | -79,056 | -60,202 | -41,309 | -43,808 |
Net Change In Cash | 1,157 | 1,083 | 2,322 | 1,666 |
Free Cash Flow | -46,882 | -57,247 | -36,223 | -38,991 |
Cash | 19,636 | 33,700 | 32,490 | 45,145 |
Basic Shares | 88,200 | 84,518 | 77,303 | 76,729 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,040 | $1,139 | $204 | $191 |
Gross Profit | -607 | -80,963 | -45,548 | 176 |
EBITDA | -159,550 | -88,007 | -48,590 | -35,427 |
EBIT | -160,995 | -88,039 | -48,607 | -35,442 |
Net Income | -160,995 | -88,039 | -48,607 | -35,443 |
Net Change In Cash | 4,040 | 1,139 | 204 | 191 |
Free Cash Flow | -132,480 | -78,947 | -45,679 | -29,818 |
Cash | 32,490 | 257,068 | 8,266 | 88,143 |
Basic Shares | 77,303 | 62,496 | 66,636 | 66,636 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.90 |
2026-03-31 | -$0.71 |
2025-12-31 | -$0.51 |
2025-09-30 | -$0.57 |